Online or In-Person TRT: The Seven Checks That Should Happen Either Way

Format is not the variable that determines quality of care — protocol is. The Endocrine Society guideline sets out what diagnosis and monitoring must include, and nothing in it depends on whether the consultation happens in a room or on a screen.[1] A telehealth service can follow it completely. So can a clinic down the road. Either can skip steps, and they tend to skip the same ones.

Here are the seven checks worth confirming before you commit to a provider of any kind.

1. Two fasting morning draws, not one

The guideline recommends fasting morning total testosterone as the initial diagnostic test, and recommends confirming the diagnosis by repeating it.[1] A provider willing to prescribe from a single reading has departed from the standard at step one.

This is the most common shortcut and the easiest to check for. Why one low result doesn't mean low testosterone covers the reasoning.

2. Symptoms documented alongside the numbers

Diagnosis is recommended only in men with symptoms and signs consistent with deficiency and consistently low concentrations.[1] Both halves. A process that collects labs without a real symptom history is not applying the guideline's definition.

3. Free testosterone when it is indicated

The guideline asks for a free testosterone concentration when total is near the lower limit of normal, or when a condition altering SHBG is present — obtained by equilibrium dialysis or an accurate formula.[1] Given how common SHBG-altering conditions are, this comes up often. See reading your testosterone results.

4. An attempt to find the cause

For a confirmed deficiency, the guideline recommends additional diagnostic evaluation to ascertain the cause.[1] Low testosterone is a finding produced by something. A service that treats the number without asking what produced it has skipped a recommendation, and it is the one most invisible to the patient.

5. Screening for the contraindications

The guideline recommends against starting testosterone in men planning fertility in the near term, or with breast or prostate cancer, a palpable prostate nodule or induration, PSA above 4 ng/mL, PSA above 3 ng/mL in men at increased risk without urological evaluation, elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, myocardial infarction or stroke within the last six months, or thrombophilia.[1]

That is a long list, and running it takes a real history. Fertility in particular is worth raising unprompted if it applies to you — it is first on the guideline's list and is not always asked about.

6. A stated target of mid-normal

The guideline suggests aiming at testosterone concentrations in the mid-normal range during treatment.[1] A provider whose stated goal is the top of the range, or who frames higher as better, is optimising against a target the guideline does not set.

7. A monitoring plan for the first year

The guideline asks for a standardised plan covering symptoms, adverse effects and compliance; serum testosterone and hematocrit; and prostate cancer risk assessment during the first year.[1] Ask what the schedule is and who reviews the results. The 3-month panel covers what that first checkpoint is looking for and why it falls where it does.

What genuinely differs between the formats

Setting protocol aside, two practical differences are worth naming honestly.

Physical examination. The guideline's contraindication list includes a palpable prostate nodule or induration — a finding from a physical exam. A remote service handles this through referral and PSA rather than in-house, so it is fair to ask how that is covered.

Continuity and records. An established in-person relationship may already hold the history that a new provider of any kind has to build. Conversely, a structured telehealth programme may run a more consistent monitoring schedule than ad-hoc follow-up. Neither is inherently better; both are worth asking about.

Frequently asked questions

Is online TRT legitimate? Legitimacy is a question about the provider, not the format. The seven checks above are the test, and they apply identically to both.

Can a telehealth provider order the right labs? Yes — what matters is that the labs ordered match what the guideline specifies: fasting morning total testosterone, repeated, with free testosterone and SHBG where indicated.[1]

What if a provider prescribes after one test? That departs from the guideline's recommendation to confirm the diagnosis by repeating the morning fasting measurement.[1] It is reasonable to ask why, and reasonable to want the second draw before starting.

Which questions matter most if I only ask two? "Will you confirm the diagnosis on a second fasting morning draw?" and "What is the monitoring schedule for the first year?" Those two cover the entry and the exit of the process, and the answers reveal most of what the rest of the protocol looks like.

What to ask for

Take the seven checks to whichever provider you are considering and ask which of them are part of their standard process. A provider following the guideline will recognise the list.

Keen connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, treatment is Keen Testosterone Spray Rx — a once-daily topical spray powered by Hypospray® transdermal delivery.

Related reading: your first testosterone test and starting TRT after 50.

References

1 source

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364